Saudis to build insulin plant

Here's a prime example of how politics affects the drug biz. Two years ago, a Danish newspaper published some cartoons that offended many Muslims and led to a boycott in some Islamic countries. Now, the Islamic Development Bank is putting up $10 million to help finance an insulin-production plant--in hopes of cutting out major insulin supplier Novo Nordisk. Which, of course, is based in Denmark.

The new plant is slated for a site near Jeddah and will be developed in partnership with Brazilian biotech Biomm. The Saudi firm leading the charge hasn't been identified.

- read the article in Dawn 

Related Articles:
Novo Nordisk reports positive data in diabetes trials. Report
Investigators probing Novo payments. Report
Amgen ups lobbying efforts. Report

Suggested Articles

Patients with epithelioid sarcoma previously had no targeted treatment options, but that'll change with Epizyme's approval for Tazverik.

With federal prosecutors laying waste to Insys' executive team, one big domino was still left to fall: Founder and former CEO John Kapoor.

Amgen buys out Astellas Japanese joint venture. Sun Piaoyang steps down as Hengrui chairman. Moderna-NIH and Inovio work on coronavirus vaccines.